| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, particularly to haematology and endocrinology, and deals with optimisation of thrombocyte receptivity to aggregation inducers in metabolic syndrome patients. For this purpose individually selected low-calorie diet, and drugs: 10 mg amploidine every morning, duovit by 1 red tablet and 1 blue one daily, are administered. The course duration is at least 12 weeks. ^ EFFECT: allows normalisation of thrombocyte receptivity to aggregation inducers, resulted in significant reducing the risk of thrombosis complications in metabolic syndrome. ^ 2 tbl, 1 ex, 3 dwg |
